209 related articles for article (PubMed ID: 14500570)
21. Metabolic response to an acute jump in cardiac workload: effects on malonyl-CoA, mechanical efficiency, and fatty acid oxidation.
Zhou L; Huang H; Yuan CL; Keung W; Lopaschuk GD; Stanley WC
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H954-60. PubMed ID: 18083904
[TBL] [Abstract][Full Text] [Related]
22. The hyperleptinemia of obesity-regulator of caloric surpluses.
Unger RH
Cell; 2004 Apr; 117(2):145-6. PubMed ID: 15084251
[TBL] [Abstract][Full Text] [Related]
23. Malonyl CoA control of fatty acid oxidation in the ischemic heart.
Dyck JR; Lopaschuk GD
J Mol Cell Cardiol; 2002 Sep; 34(9):1099-109. PubMed ID: 12392882
[TBL] [Abstract][Full Text] [Related]
24. Regulation of cardiac malonyl-CoA content and fatty acid oxidation during increased cardiac power.
King KL; Okere IC; Sharma N; Dyck JR; Reszko AE; McElfresh TA; Kerner J; Chandler MP; Lopaschuk GD; Stanley WC
Am J Physiol Heart Circ Physiol; 2005 Sep; 289(3):H1033-7. PubMed ID: 15821035
[TBL] [Abstract][Full Text] [Related]
25. AMPK as a metabolic switch in rat muscle, liver and adipose tissue after exercise.
Ruderman NB; Park H; Kaushik VK; Dean D; Constant S; Prentki M; Saha AK
Acta Physiol Scand; 2003 Aug; 178(4):435-42. PubMed ID: 12864749
[TBL] [Abstract][Full Text] [Related]
26. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha.
Yoon MJ; Lee GY; Chung JJ; Ahn YH; Hong SH; Kim JB
Diabetes; 2006 Sep; 55(9):2562-70. PubMed ID: 16936205
[TBL] [Abstract][Full Text] [Related]
27. Long-chain acyl-CoA esters inhibit phosphorylation of AMP-activated protein kinase at threonine-172 by LKB1/STRAD/MO25.
Taylor EB; Ellingson WJ; Lamb JD; Chesser DG; Winder WW
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1055-61. PubMed ID: 15644453
[TBL] [Abstract][Full Text] [Related]
28. AMPK activation is not critical in the regulation of muscle FA uptake and oxidation during low-intensity muscle contraction.
Raney MA; Yee AJ; Todd MK; Turcotte LP
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E592-8. PubMed ID: 15547141
[TBL] [Abstract][Full Text] [Related]
29. Malonyl-CoA and AMP-activated protein kinase: an expanding partnership.
Saha AK; Ruderman NB
Mol Cell Biochem; 2003 Nov; 253(1-2):65-70. PubMed ID: 14619957
[TBL] [Abstract][Full Text] [Related]
30. Malonyl-CoA decarboxylase is not a substrate of AMP-activated protein kinase in rat fast-twitch skeletal muscle or an islet cell line.
Habinowski SA; Hirshman M; Sakamoto K; Kemp BE; Gould SJ; Goodyear LJ; Witters LA
Arch Biochem Biophys; 2001 Dec; 396(1):71-9. PubMed ID: 11716464
[TBL] [Abstract][Full Text] [Related]
31. AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms.
Xiang X; Saha AK; Wen R; Ruderman NB; Luo Z
Biochem Biophys Res Commun; 2004 Aug; 321(1):161-7. PubMed ID: 15358229
[TBL] [Abstract][Full Text] [Related]
32. Hypothalamic malonyl-CoA and CPT1c in the treatment of obesity.
Wolfgang MJ; Lane MD
FEBS J; 2011 Feb; 278(4):552-8. PubMed ID: 21199367
[TBL] [Abstract][Full Text] [Related]
33. The AMPK-malonyl-CoA-CPT1 axis in the control of hypothalamic neuronal function.
Zammit VA; Arduini A
Cell Metab; 2008 Sep; 8(3):175; author reply 176. PubMed ID: 18762014
[No Abstract] [Full Text] [Related]
34. Exercise training decreases the concentration of malonyl-CoA and increases the expression and activity of malonyl-CoA decarboxylase in human muscle.
Kuhl JE; Ruderman NB; Musi N; Goodyear LJ; Patti ME; Crunkhorn S; Dronamraju D; Thorell A; Nygren J; Ljungkvist O; Degerblad M; Stahle A; Brismar TB; Andersen KL; Saha AK; Efendic S; Bavenholm PN
Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1296-303. PubMed ID: 16434556
[TBL] [Abstract][Full Text] [Related]
35. AMPK regulation of the growth of cultured human keratinocytes.
Saha AK; Persons K; Safer JD; Luo Z; Holick MF; Ruderman NB
Biochem Biophys Res Commun; 2006 Oct; 349(2):519-24. PubMed ID: 16949049
[TBL] [Abstract][Full Text] [Related]
36. Effect of phosphorylation by AMP-activated protein kinase on palmitoyl-CoA inhibition of skeletal muscle acetyl-CoA carboxylase.
Rubink DS; Winder WW
J Appl Physiol (1985); 2005 Apr; 98(4):1221-7. PubMed ID: 15579580
[TBL] [Abstract][Full Text] [Related]
37. Malonyl-CoA, fuel sensing, and insulin resistance.
Ruderman NB; Saha AK; Vavvas D; Witters LA
Am J Physiol; 1999 Jan; 276(1):E1-E18. PubMed ID: 9886945
[TBL] [Abstract][Full Text] [Related]
38. Activation of AMP-activated Protein Kinase by Metformin Induces Protein Acetylation in Prostate and Ovarian Cancer Cells.
Galdieri L; Gatla H; Vancurova I; Vancura A
J Biol Chem; 2016 Nov; 291(48):25154-25166. PubMed ID: 27733682
[TBL] [Abstract][Full Text] [Related]
39. Hypothalamic malonyl-CoA triggers mitochondrial biogenesis and oxidative gene expression in skeletal muscle: Role of PGC-1alpha.
Cha SH; Rodgers JT; Puigserver P; Chohnan S; Lane MD
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15410-5. PubMed ID: 17030788
[TBL] [Abstract][Full Text] [Related]
40. Malonyl-CoA and AMP-activated protein kinase (AMPK): possible links between insulin resistance in muscle and early endothelial cell damage in diabetes.
Ruderman NB; Cacicedo JM; Itani S; Yagihashi N; Saha AK; Ye JM; Chen K; Zou M; Carling D; Boden G; Cohen RA; Keaney J; Kraegen EW; Ido Y
Biochem Soc Trans; 2003 Feb; 31(Pt 1):202-6. PubMed ID: 12546685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
